Inflarx announces participation in guggenheim smid cap biotech conference

Jena, germany, jan. 23, 2025 (globe newswire) -- inflarx n.v. (nasdaq: ifrx), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it will participate in the guggenheim smid cap biotech conference, to be held february 5 – 6, 2025 in new york, ny.
SMID Ratings Summary
SMID Quant Ranking